Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives. Structure-activity relationships

Scorza, M.C.; Carrau C.; Silveira, R.; Reyes-Parada, M; Zapata-Torres, G; Cassels, B.K.

Keywords: chemistry, acid, inhibition, rat, enzyme, animals, serotonin, brain, rats, structure, nucleus, mitochondrion, experiment, male, oxidase, time, vitro, amphetamine, isoenzyme, tissue, hippocampus, dose, drug, inhibitors, article, amphetamines, activity, selegiline, amine, raphe, controlled, animal, relation, study, relationship, derivative, priority, in, intraperitoneal, administration, nonhuman, journal, Structure-Activity, a, amiflamine, effect, 5, b, hydroxyindoleacetic, (flavin, containing), clorgyline, Monoamine

Abstract

The monoamine oxidase (MAO) inhibitory properties of a series of amphetamine derivatives with different substituents at or around the para position of the aromatic ring were evaluated. In in vitro studies in which a crude rat brain mitochondrial suspension was used as the source of MAO, several compounds showed a strong (IC50 in the submicromolar range), selective, reversible, time-independent, and concentration-related inhibition of MAO-A. After i.p. injection, the compounds induced an increase of serotonin and a decrease of 5-hydroxyindoleacetic acid in the raphe nuclei and hippocampus, confirming the in vitro results. The analysis of structure-activity relationships indicates that: molecules with amphetamine-like structure and different substitutions on the aromatic ring are potentially MAO-A inhibitors; substituents at different positions of the aromatic ring modify the potency but have little influence on the selectivity; substituents at the para position such as amino, alkoxyl, halogens, or alkylthio produce a significant increase in the activity; the para-substituent must be an electron donor; bulky groups next to the para substituent lead to a decrease in the activity; substituents located at positions more distant on the aromatic ring have less influence and, even when the substituent is a halogen (Cl, Br), an increase in the activity of the compound is obtained. Finally, the MAO-A inhibitory properties of some of the compounds evaluated are discussed in relation to: (a) potential antidepressant activity, and (b) their reported hallucinogenic, neurotoxic, or anxiolytic effects.

Más información

Título de la Revista: BIOCHEMICAL PHARMACOLOGY
Volumen: 54
Número: 12
Editorial: PERGAMON-ELSEVIER SCIENCE LTD
Fecha de publicación: 1997
Página de inicio: 1361
Página final: 1369
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-0000206859&partnerID=q2rCbXpz